Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glecaprevir/Pibrentasvir in HCV/HIV-1 Co-Infection
NCT02738138Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- May 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of glecaprevir + pibrentasvir in hepatitis C (HCV), sponsored by AbbVie Inc.. Started May 2016; status: completed.
02
Drugs
glecaprevir + pibrentasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02738138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02738138.